These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7189454)

  • 1. The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women.
    Back DJ; Breckenridge AM; Crawford FE; Hall JM; MacIver M; Orme ML; Rowe PH; Smith E; Watts MJ
    Contraception; 1980 Feb; 21(2):135-43. PubMed ID: 7189454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy.
    Back DJ; Bates M; Bowden A; Breckenridge AM; Hall MJ; Jones H; MacIver M; Orme M; Perucca E; Richens A; Rowe PH; Smith E
    Contraception; 1980 Nov; 22(5):495-503. PubMed ID: 7471739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ampicillin on oral contraceptive steroids in women.
    Back DJ; Breckenridge AM; MacIver M; Orme M; Rowe PH; Staiger C; Thomas E; Tjia J
    Br J Clin Pharmacol; 1982 Jul; 14(1):43-8. PubMed ID: 6809025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.
    Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Watts MJ
    Contraception; 1979 Sep; 20(3):263-73. PubMed ID: 509953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE; Doose DR; Walker SA; Nayak RK
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG; Dai Y
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.
    Orme ML
    Br J Clin Pharmacol; 1982 Jul; 14(1):31-42. PubMed ID: 7049209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
    Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
    Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of interaction of low-dose combination oral contraceptive with Ampicillin and Metronidazole.
    Joshi JV; Joshi UM; Sankholi GM; Krishna U; Mandlekar A; Chowdhury V; Hazari K; Gupta K; Sheth UK; Saxena BN
    Contraception; 1980 Dec; 22(6):643-52. PubMed ID: 7214911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of gestodene and ethinylestradiol in 14 women during three months of treatment with a new tri-step combination oral contraceptive: serum protein binding of gestodene and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W; Baumann A; Staks T; Dibbelt L; Knuppen R; Jütting G
    Contraception; 1993 Oct; 48(4):303-22. PubMed ID: 8222659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
    Song S; Chen JK; He ML; Fotherby K
    Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man.
    Bolt HM; Bolt M; Kappus H
    Acta Endocrinol (Copenh); 1977 May; 85(1):189-197. PubMed ID: 577076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interactions with oral contraceptive steroids.
    Back DJ; Breckenridge AM; Orme ML
    IPPF Med Bull; 1983 Feb; 17(1):1-2. PubMed ID: 12264750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of interaction between temafloxacin and combined oral contraceptive steroids.
    Back DJ; Tjia J; Martin C; Millar E; Mant T; Morrison P; Orme M
    Contraception; 1991 Apr; 43(4):317-23. PubMed ID: 1906791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W; al-Yacoub G; Fuhrmeister A
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.